Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-09 @ 10:32 AM
Study NCT ID:
NCT06805812
Status:
RECRUITING
Last Update Posted:
2025-02-03
First Post:
2025-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
INT101/23
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER_GOV | View |
| None | NETWORK | View |
| None | OTHER | View |
| None | OTHER | View |